We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Endogenous Human Proteins Interfering with Amyloid Formation.
- Authors
Gharibyan, Anna L.; Wasana Jayaweera, Sanduni; Lehmann, Manuela; Anan, Intissar; Olofsson, Anders
- Abstract
Amyloid formation is a pathological process associated with a wide range of degenerative disorders, including Alzheimer's disease, Parkinson's disease, and diabetes mellitus type 2. During disease progression, abnormal accumulation and deposition of proteinaceous material are accompanied by tissue degradation, inflammation, and dysfunction. Agents that can interfere with the process of amyloid formation or target already formed amyloid assemblies are consequently of therapeutic interest. In this context, a few endogenous proteins have been associated with an anti-amyloidogenic activity. Here, we review the properties of transthyretin, apolipoprotein E, clusterin, and BRICHOS protein domain which all effectively interfere with amyloid in vitro, as well as displaying a clinical impact in humans or animal models. Their involvement in the amyloid formation process is discussed, which may aid and inspire new strategies for therapeutic interventions.
- Subjects
AMYLOID beta-protein; AMYLOID; TYPE 2 diabetes; PROTEIN domains; CLUSTERIN; TRANSTHYRETIN; APOLIPOPROTEIN E
- Publication
Biomolecules (2218-273X), 2022, Vol 12, Issue 3, p446
- ISSN
2218-273X
- Publication type
Article
- DOI
10.3390/biom12030446